Sunil Cutinho Sells 4,500 Shares of CME Group Inc. (NASDAQ:CME) Stock

CME Group Inc. (NASDAQ:CME) insider Sunil Cutinho sold 4,500 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

CME Group Price Performance

Shares of CME opened at $225.36 on Friday. The company has a market capitalization of $81.14 billion, a P/E ratio of 25.64, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a 50 day moving average of $220.36 and a 200 day moving average of $209.34. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.25 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently made changes to their positions in the company. AIA Group Ltd grew its position in CME Group by 5.3% in the 3rd quarter. AIA Group Ltd now owns 22,669 shares of the financial services provider’s stock worth $5,002,000 after purchasing an additional 1,137 shares during the period. Summit Global Investments grew its position in CME Group by 62.0% in the 3rd quarter. Summit Global Investments now owns 2,057 shares of the financial services provider’s stock worth $454,000 after purchasing an additional 787 shares during the period. Verity Asset Management Inc. bought a new stake in CME Group in the 3rd quarter worth approximately $341,000. Portside Wealth Group LLC grew its position in CME Group by 55.2% in the 3rd quarter. Portside Wealth Group LLC now owns 3,848 shares of the financial services provider’s stock worth $849,000 after purchasing an additional 1,368 shares during the period. Finally, Keynote Financial Services LLC bought a new stake in CME Group in the 3rd quarter worth approximately $327,000. Institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the subject of several research analyst reports. TD Cowen initiated coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Bank of America raised their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Citigroup raised their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Finally, Piper Sandler raised their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $222.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.